Disruption of SSR4 is now known to cause congenital disorder of glycosylation type 1 y (CDG1Y; OMIM #300934) an X-linked disorder characterized by developmental delay, muscular hypotonia, microcephaly, and distinctive facial features. Here, SSR4 is linked to Global developmental delay.